Tag: ASX: SPL
Starpharma inks partnership to distribute VivaGel BV product in MENA region
Australian biopharmaceutical company Starpharma has secured a sales and distribution agreement for its VivaGel BV product in the Middle East and North Africa (MENA) region.
Starpharma launches R&D partnership with UQ to advance DEP cancer treatment products
Biopharmaceutical company Starpharma Holdings has ventured into a partnership with the University of Queensland’s (UQ) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub) to advance research and development on the ASX company’s targeted DEP radiotheranostic products.
Featured Article
GridBeyond highlights role of technology in navigating energy market swings
Energy price volatility continues to pose challenges for manufacturers and other energy-intensive industries, particularly as electricity markets experience more frequent and unpredictable price swings.
